Leica Biosystems Launches Aperio PeerReview for Toxicological Pathology

News provided by

Sep 10, 2014, 11:57 ET

VISTA, California, September 10, 2014 /PRNewswire/ --

Leica Biosystems Launches Aperio Peerreview for Toxicological Pathology (PRNewsFoto/Leica Biosystems)

Leica Biosystems, a global leader in automation and workflow solutions for anatomic pathology, announced the launch of Aperio PeerReviewTM, a complete digital pathology software solution for toxicological pathologists conducting peer review studies in pre-clinical trials.

(Photo: http://photos.prnewswire.com/prnh/20140910/705629 )

With barcode-driven automated integration of LIMS data and images, combined with customized viewing functionality, specific for toxicological pathology, Aperio PeerReview helps to reduce costs and improve efficiency in pre-clinical testing. Remote access to peer review slides and simultaneous, real-time discussion of non-concordant samples means that pathologists can conduct peer review studies without shipping slides or traveling.

"Aperio PeerReview is a significant breakthrough for pharmaceutical companies and CROs. It has been designed and developed in close collaboration with world-leading toxicological pathologists," said Anne Brumme, VP of ePathology at Leica Biosystems. "This launch further expands our range of solutions and demonstrates our commitment to satisfy the needs of the life science market."

Erio Barale-Thomas, principal scientist at Johnson & Johnson R&D will be presenting a complimentary webinar, "Peer Review through Digital Pathology: The Future is now?" September 30, 2014, focusing on the usage of Aperio PeerReview in toxicologic pathology. To learn more about Aperio PeerReview, please visit LeicaBiosytems.com/AperioPeerReview.

About Leica Biosystems

Leica Biosystems is a global leader in workflow solutions and automation, striving to advance cancer diagnostics to improve patients' lives. Leica Biosystems provides anatomic pathology laboratories and researchers a comprehensive product range for each step in the pathology process, from sample preparation and staining to imaging and reporting. Leica's easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence. The company is represented in over 100 countries. It has manufacturing facilities in 7 countries, sales and service organizations in 19 countries, and an international network of dealers. The company is headquartered in Nussloch, Germany. Further information can be found at LeicaBiosystems.com.

SOURCE Leica Biosystems